查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1233130

2023-2030 年按類型（遠端甲癬、淺表白色甲癬、近端甲癬）、治療方法（口服、局部）、按地區劃分的甲癬市場規模、份額和趨勢分析報告

Onychomycosis Market Size, Share & Trends Analysis Report By Type (Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis), By Treatment (Oral, Topical), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10個工作天內

價格

甲癬市場增長和趨勢

Grand View Research, Inc. 的最新報告顯示，全球甲真菌病市場從 2022 年到 2030 年將以 4.56% 的複合年增長率增長，預計到 2030 年將達到 49.2 億美元

甲癬市場的增長歸因於甲癬和慢性病發病率的增加，以及治療意識的提高。 傳染病會造成心理和社會局限性，並會干擾工作和社交生活，因此為患有傳染病的患者提供有效和高效的治療非常重要。進一步促進增長。

甲癬發病率的上升是促進整個市場增長的主要因素。 這種感染稱為趾甲真菌或真菌性指甲感染，影響美國總人口的 14% 以上。 然而，指甲真菌具有高度傳染性，大多數人都沒有意識到它的危害，儘管患上它的風險會隨著年齡的增長而增加。

全球灰指甲組織等國際組織正在與世界各地的公共衛生當局和醫療保健專業人員合作，以提高全世界對灰指甲的認識，改善預防和治療。是。 預計這將推動對治療藥物的需求。 美國疾病控制和預防中心 (CDC) 發起的“Think Fungus”等政府舉措強調了早期發現和適當治療真菌病（如患者的甲癬）的重要性。。 因此，預計對甲癬藥物的需求將飆升，從而推動該國的市場增長。

此外，主要參與者正專注於聯合研究和合作夥伴關係，以開發新型甲癬治療方法並保持市場競爭力。 例如，2022 年 8 月，Moberg Pharma AB 將與 Padagis Israel Agencies Ltd. 簽訂分銷協議，授予 Padagis 在以色列獨家銷售和營銷 MOB-015（一種治療甲癬的藥物）的權利。 此外，解決諸如提高患者依從性和減少劑量等問題的創新有望推動市場增長。 例如，2021 年 10 月，Intus Pharmaceuticals 推出了商品名為 Itaspor-SB Forte/Subawin 的 SB 100mg，這是世界上第一個具有超強生物利用度的伊曲康唑。 這一舉措有望顯著提高患者的依從性並降低治療成本。

甲癬市場報告要點

  • 遠端甲下癬細分市場將在 2022 年佔據市場主導地位，原因是 FDA 為滿足不斷增長的需求而批准的仿製藥數量不斷增加。
  • 由於外用藥物易於使用和管理，可提高患者的依從性，因此預計在預測期內其增長率最快。
  • 競爭對手專注於獲得資本密集型專業能力，以加強和保持競爭優勢。
  • 北美在 2022 年佔據了最大的市場份額，這可能是由於更容易獲得醫療保健、更廣泛的人口覆蓋率和更高的治療普及率。

內容

第 1 章甲癬市場：研究方法和範圍

  • 市場細分
    • 細分範圍
    • 區域範圍
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
    • 初步調查的詳細信息
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 模型詳細信息
    • 商品流分析
      • 方法 1：商品流方法
      • 方法 2：使用自下而上的方法按國家/地區進行市場預測
      • 方法 2：使用自上而下的方法逐個國家/地區進行市場估算
  • 全球市場：CAGR 計算
  • 次要信息列表
  • 目的
  • 縮寫列表

第 2 章甲癬市場：執行摘要

  • 市場概況
  • 片段快照
  • 競爭格局快照

第 3 章甲真菌病市場：行業展望

  • 市場系列展望
    • 母市場沿襲預測
    • 相關/子公司市場前景
  • 描繪滲透率和增長前景
  • 市場動態
    • 市場驅動力
      • 甲癬和慢性病的發病率增加
      • 提高對甲癬治療的認識
      • 玩家加大研發力度
      • 老年人口和糖尿病人口增加
    • 市場製約因素分析
      • 增加抗真菌藥物的耐藥性
  • SWOT 分析，按因素（政治和法律、經濟和技術）
  • 行業分析 - 搬運工
  • 報銷和監管場景
  • 主要交易和戰略聯盟
    • 新產品發布
    • 得到
    • 分機
    • 夥伴關係
    • 營銷和推廣

第 4 章甲真菌病市場：競爭格局

  • 近期發展和影響分析：主要市場進入者
    • 安索夫矩陣
  • 公司分類
    • 創新者
      • 市場差異化因素
  • 供應商情況
    • 主要分銷商和渠道合作夥伴列表
    • 主要客戶
    • 2022 年主要參與者的市場份額分析
  • 上市公司
    • 競爭儀錶盤分析
  • 私人公司
    • 主要初創企業名單
  • 本地網絡地圖

第 5 章甲癬市場：類型業務分析

  • 定義和範圍
  • 類型市場份額分析，2022 年和 2030 年
  • 全球甲癬市場，按類型，2018-2030 年
  • 甲癬市場：類型變異分析
  • 遠端甲下甲癬
  • 白色淺癬甲癬
  • 近端甲下甲癬
  • 其他類型

第 6 章甲癬市場：治療業務分析

  • 定義和範圍
  • 2022 年和 2030 年治療市場份額分析
  • 全球甲癬市場，按治療方式，2018-2030 年
  • 結核病治療市場：治療波動分析
  • 口語
  • 主題
  • 其他

第 7 章。甲癬市場：區域業務分析

  • 定義和範圍
  • 2022 年和 2030 年區域市場份額分析
  • 區域市場儀表板
  • 區域市場概況
  • SWOT 分析，按因素（政治和法律、經濟和技術）
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 多邊環境協定
  • 2022-2030 年市場規模、預測、趨勢分析
  • 北美
    • 美國
      • 主要國家動態
      • 監管框架
      • 競爭場景
      • 導入導出場景
      • 投資場景
    • 加拿大
      • 主要國家動態
      • 監管框架
      • 競爭場景
      • 導入導出場景
      • 投資場景
  • 歐洲
    • 英國
      • 主要國家動態
      • 監管框架
      • 競爭場景
      • 導入導出場景
      • 投資場景
    • 德國
      • 主要國家動態
      • 監管框架
      • 競爭場景
      • 導入導出場景
      • 投資場景
    • 西班牙
      • 主要國家動態
      • 監管框架
      • 競爭場景
      • 導入導出場景
      • 投資場景
    • 法國
      • 主要國家動態
      • 監管框架
      • 競爭場景
      • 導入導出場景
      • 投資場景
    • 意大利
      • 主要國家動態
      • 監管框架
      • 競爭場景
      • 導入導出場景
      • 投資場景
    • 俄羅斯
      • 監管框架
      • 競爭場景
      • 導入導出場景
      • 投資場景
    • 丹麥
      • 主要國家動態
      • 監管框架
      • 競爭場景
      • 導入導出場景
      • 投資場景
    • 瑞典
      • 主要國家動態
      • 監管框架
      • 競爭場景
      • 導入導出場景
      • 投資場景
    • 挪威
      • 主要國家動態
      • 監管框架
      • 競爭場景
      • 導入導出場景
      • 投資場景
  • 亞太地區
    • 日本
      • 主要國家動態
      • 監管框架
      • 競爭場景
      • 導入導出場景
      • 投資場景
    • 中國
      • 主要國家動態
      • 監管框架
      • 競爭場景
      • 導入導出場景
      • 投資場景
    • 印度
      • 主要國家動態
      • 監管框架
      • 競爭場景
      • 導入導出場景
      • 投資場景
    • 韓國
      • 主要國家動態
      • 監管框架
      • 競爭場景
      • 導入導出場景
      • 投資場景
    • 泰國
      • 主要國家動態
      • 監管框架
      • 競爭場景
      • 導入導出場景
      • 投資場景
    • 澳大利亞
      • 主要國家動態
      • 監管框架
      • 競爭場景
      • 導入導出場景
      • 投資場景
  • 拉丁美洲
    • 巴西
      • 主要國家動態
      • 監管框架
      • 競爭場景
      • 導入導出場景
      • 投資場景
    • 墨西哥
      • 主要國家動態
      • 監管框架
      • 競爭場景
      • 導入導出場景
      • 投資場景
    • 阿根廷
      • 主要國家動態
      • 監管框架
      • 競爭場景
      • 導入導出場景
      • 投資場景
  • 多邊環境協定
    • 南非
      • 主要國家動態
      • 監管框架
      • 競爭場景
      • 導入導出場景
      • 投資場景
    • 沙特阿拉伯
      • 主要國家動態
      • 監管框架
      • 競爭場景
      • 導入導出場景
      • 投資場景
    • 阿拉伯聯合酋長國
      • 主要國家動態
      • 監管框架
      • 競爭場景
      • 導入導出場景
      • 投資場景
    • 科威特
      • 主要國家動態
      • 監管框架
      • 競爭場景
      • 導入導出場景
      • 投資場景

第 8 章甲癬市場：公司概況

  • 公司簡介
    • Bausch Health Companies Inc.,
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 葛蘭素史克
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 雅培
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • F. 輝瑞公司，
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 拜耳公司
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 梯瓦製藥工業有限公司
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 西普拉公司
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 諾華公司
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 太陽製藥工業有限公司
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 默克公司
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
Product Code: GVR-4-68040-031-4

Onychomycosis Market Growth & Trends:

The global onychomycosis market is expected to reach USD 4.92 billion by 2030, expanding at a CAGR of 4.56% from 2022 to 2030, according to a new report by Grand View Research, Inc. The growth of the onychomycosis market is attributable to the increasing incidence of onychomycosis and chronic diseases aided by rising awareness about treatment. The infection leads to psychological and social limitations which can limit an individual's ability to work and socialize which makes it important to provide effective and efficient treatment for patients suffering from the infection further propelling the market growth.

Rising rate of onychomycosis is the key factor contributing to the overall growth of the market. The infection, often known as toenail fungus or fungal nail infection, affects over 14% of the total population in the U.S. However, most people are unaware of how harmful toenail fungus is, despite it is extremely contagious in nature and increasing the risk of developing with age.

International organizations such as the Global Nail Fungus Organization are working with public health officials and healthcare professionals worldwide to increase awareness and improve the prevention and treatment of nail fungus across the globe. This is anticipated to propel the demand for therapeutics. Government initiatives such as Think Fungus by the Centers for Disease Control and Prevention (CDC), emphasize the significance of detecting fungal diseases such as onychomycosis, early enough in the course of a patient's condition to ensure the administration of relevant therapy. This is inducing a surge in demand for onychomycosis therapeutics and is expected to drive market growth in the country.

Furthermore, the key players are focusing on collaborations and partnerships to develop novel onychomycosis therapies and to maintain their competitive position in the market. For instance, in August 2022, Moberg Pharma AB entered into a distribution agreement with Padagis Israel Agencies Ltd. that is expected to give Padagis exclusive rights for selling and marketing MOB-015, a treatment for onychomycosis in Israel. Moreover, innovations to address the concerns such as improving patient compliance and reducing the dosage are expected to fuel the market growth. For instance, in October 2021, Intas Pharmaceuticals launched SB 100mg under the brand name Itaspor-SB Forte/Subawin which is the world's first Super Bioavailable Itraconazole. This initiative is expected to significantly increase patient compliance and reduce the cost of therapy.

Onychomycosis Market Report Highlights:

  • Distal subungual onychomycosis segment dominated the market in 2022 and is attributable to the increasing prevalence and number of generic approvals by the FDA to meet the rising demands
  • Topical segment is expected to show the fastest growth rate over the forecast period owing to ease of usage and administration which leads to increased patient compliance with treatment
  • Players have an increased focus on acquiring specialized capacities that are highly capital-intensive to develop and maintain their competitive position
  • North America held the largest market share in 2022 which can be attributed to better access to healthcare, the presence of a wide target population, and high adoption of treatment

Table of Contents

Chapter 1 Onychomycosis Market: Methodology And Scope

  • 1.1 Market Segmentation
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.6.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
      • 1.6.1.3 Approach 2: Country Wise Market Estimation Using Top Down Approach
  • 1.7 Global Market: Cagr Calculation
  • 1.8 List Of Secondary Sources
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2
  • 1.10 List Of Abbreviations

Chapter 2 Onychomycosis Market: Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Onychomycosis Market: Industry Outlook

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Lineage Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Drivers
      • 3.3.1.1 Increasing Incidence Of Onychomycosis And Chronic Diseases
      • 3.3.1.2 Rising Awareness About Treatment Of Onychomycosis
      • 3.3.1.3 Escalating R&D Efforts By Players
      • 3.3.1.4 Growing Geriatric Population And Diabetic Population
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Increasing Resistance To Antifungal Drugs
  • 3.4 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
  • 3.5 Industry Analysis - Porter's
  • 3.6 Reimbursement & Regulatory Scenario
  • 3.7 Major Deals & Strategic Alliances
    • 3.7.1 New Product Launch
    • 3.7.2 Acquisition
    • 3.7.3 Expansion
    • 3.7.4 Partnerships
    • 3.7.5 Marketing & Promotions

Chapter 4 Onychomycosis Market: Competitive Landscape

  • 4.1 Recent Developments & Impact Analysis, By Key Market Participants
    • 4.1.1 Ansoff Matrix
  • 4.2 Company Categorization
    • 4.2.1 Innovators
      • 4.2.1.1 Market Differentiators
  • 4.3 Vendor Landscape
    • 4.3.1 List Of Key Distributors And Channel Partners
    • 4.3.2 Key Customers
    • 4.3.3 Key Company Market Share Analysis, 2022
  • 4.4 Public Companies
    • 4.4.1 Competitive Dashboard Analysis
  • 4.5 Private Companies
    • 4.5.1 List Of Key Emerging Companies
  • 4.6 Regional Network Map

Chapter 5 Onychomycosis Market: Type Business Analysis

  • 5.1 Definition And Scope
  • 5.2 Type Market Share Analysis, 2022 & 2030
  • 5.3 Global Onychomycosis Market, By Type, 2018 To 2030
  • 5.4 Onychomycosis Market: Type Movement Analysis
  • 5.5 Distal Subungual Onychomycosis
    • 5.5.1 Distal Subungual Onychomycosis Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.6 White Superficial Onychomycosis
    • 5.6.1 White Superficial Onychomycosis Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.7 Proximal Subungual Onychomycosis
    • 5.7.1 Proximal Subungual Onychomycosis Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.8 Other Types
    • 5.8.1 Other Types Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 Onychomycosis Market: Treatment Business Analysis

  • 6.1 Definition And Scope
  • 6.2 Treatment Market Share Analysis, 2022 & 2030
  • 6.3 Global Onychomycosis Market, By Treatment, 2018 To 2030
  • 6.4 Tuberculosis Therapeutics Market: Treatment Movement Analysis
  • 6.5 Oral
    • 6.5.1 Oral Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.6 Topical
    • 6.6.1 Topical Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.7 Others
    • 6.7.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 Onychomycosis Market: Regional Business Analysis

  • 7.1 Definition & Scope
  • 7.2 Regional Market Share Analysis, 2022 & 2030
  • 7.3 Regional Market Dashboard
  • 7.4 Regional Market Snapshot
  • 7.5 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
    • 7.5.1 North America
    • 7.5.2 Europe
    • 7.5.3 Asia Pacific
    • 7.5.4 Latin America
    • 7.5.5 MEA
  • 7.6 Market Size, & Forecasts, Trend Analysis, 2022 To 2030
  • 7.7 North America
    • 7.7.1 North America Onychomycosis Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.7.2 U.S.
      • 7.7.2.1 U.S. Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.7.2.2 Key Country Dynamics
      • 7.7.2.3 Regulatory Framework
      • 7.7.2.4 Competitive Scenario
      • 7.7.2.5 Import Export Scenario
      • 7.7.2.6 Investments Scenario
    • 7.7.3 Canada
      • 7.7.3.1 Canada Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.7.3.2 Key Country Dynamics
      • 7.7.3.3 Regulatory Framework
      • 7.7.3.4 Competitive Scenario
      • 7.7.3.5 Import Export Scenario
      • 7.7.3.6 Investments Scenario
  • 7.8 Europe
    • 7.8.1 Europe Onychomycosis Market, 2018 - 2030 (USD Million)
    • 7.8.2 U.K.
      • 7.8.2.1 U.K. Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.8.2.2 Key Country Dynamics
      • 7.8.2.3 Regulatory Framework
      • 7.8.2.4 Competitive Scenario
      • 7.8.2.5 Import Export Scenario
      • 7.8.2.6 Investments Scenario
    • 7.8.3 Germany
      • 7.8.3.1 Germany Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.8.3.2 Key Country Dynamics
      • 7.8.3.3 Regulatory Framework
      • 7.8.3.4 Competitive Scenario
      • 7.8.3.5 Import Export Scenario
      • 7.8.3.6 Investments Scenario
    • 7.8.4 Spain
      • 7.8.4.1 Spain Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.8.4.2 Key Country Dynamics
      • 7.8.4.3 Regulatory Framework
      • 7.8.4.4 Competitive Scenario
      • 7.8.4.5 Import Export Scenario
      • 7.8.4.6 Investments Scenario
    • 7.8.5 France
      • 7.8.5.1 France Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.8.5.2 Key Country Dynamics
      • 7.8.5.3 Regulatory Framework
      • 7.8.5.4 Competitive Scenario
      • 7.8.5.5 Import Export Scenario
      • 7.8.5.6 Investments Scenario
    • 7.8.6 Italy
      • 7.8.6.1 Italy Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.8.6.2 Key Country Dynamics
      • 7.8.6.3 Regulatory Framework
      • 7.8.6.4 Competitive Scenario
      • 7.8.6.5 Import Export Scenario
      • 7.8.6.6 Investments Scenario
    • 7.8.7 Russia
      • 7.8.7.1 Russia Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.8.7.3 Regulatory Framework
      • 7.8.7.4 Competitive Scenario
      • 7.8.7.5 Import Export Scenario
      • 7.8.7.6 Investments Scenario
    • 7.8.8 Denmark
      • 7.8.8.1 Denmark Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.8.8.2 Key Country Dynamics
      • 7.8.8.3 Regulatory Framework
      • 7.8.8.4 Competitive Scenario
      • 7.8.8.5 Import Export Scenario
      • 7.8.8.6 Investments Scenario
    • 7.8.9 Sweden
      • 7.8.9.1 Sweden Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.8.9.2 Key Country Dynamics
      • 7.8.9.3 Regulatory Framework
      • 7.8.9.4 Competitive Scenario
      • 7.8.9.5 Import Export Scenario
      • 7.8.9.6 Investments Scenario
    • 7.8.10 Norway
      • 7.8.10.1 Norway Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.8.10.2 Key Country Dynamics
      • 7.8.10.3 Regulatory Framework
      • 7.8.10.4 Competitive Scenario
      • 7.8.10.5 Import Export Scenario
      • 7.8.10.6 Investments Scenario
  • 7.9 Asia Pacific
    • 7.9.1 Asia-Pacific Onychomycosis Market, 2018 - 2030 (USD Million)
    • 7.9.2 Japan
      • 7.9.2.1 Japan Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.9.2.2 Key Country Dynamics
      • 7.9.2.3 Regulatory Framework
      • 7.9.2.4 Competitive Scenario
      • 7.9.2.5 Import Export Scenario
      • 7.9.2.6 Investments Scenario
    • 7.9.3 China
      • 7.9.3.1 China Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.9.3.2 Key Country Dynamics
      • 7.9.3.3 Regulatory Framework
      • 7.9.3.4 Competitive Scenario
      • 7.9.3.5 Import Export Scenario
      • 7.9.3.6 Investments Scenario
    • 7.9.4 India
      • 7.9.4.1 India Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.9.4.2 Key Country Dynamics
      • 7.9.4.3 Regulatory Framework
      • 7.9.4.4 Competitive Scenario
      • 7.9.4.5 Import Export Scenario
      • 7.9.4.6 Investments Scenario
    • 7.9.5 South Korea
      • 7.9.5.1 South Korea Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.9.5.2 Key Country Dynamics
      • 7.9.5.3 Regulatory Framework
      • 7.9.5.4 Competitive Scenario
      • 7.9.5.5 Import Export Scenario
      • 7.9.5.6 Investments Scenario
    • 7.9.6 Thailand
      • 7.9.6.1 Thailand Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.9.6.2 Key Country Dynamics
      • 7.9.6.3 Regulatory Framework
      • 7.9.6.4 Competitive Scenario
      • 7.9.6.5 Import Export Scenario
      • 7.9.6.6 Investments Scenario
    • 7.9.7 Australia
      • 7.9.7.1 Australia Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.9.7.2 Key Country Dynamics
      • 7.9.7.3 Regulatory Framework
      • 7.9.7.4 Competitive Scenario
      • 7.9.7.5 Import Export Scenario
      • 7.9.7.6 Investments Scenario
  • 7.10 Latin America
    • 7.10.1 Latin America Onychomycosis Market, 2018 - 2030 (USD Million)
    • 7.10.2 Brazil
      • 7.10.2.1 Brazil Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.10.2.2 Key Country Dynamics
      • 7.10.2.3 Regulatory Framework
      • 7.10.2.4 Competitive Scenario
      • 7.10.2.5 Import Export Scenario
      • 7.10.2.6 Investments Scenario
    • 7.10.3 Mexico
      • 7.10.3.1 Mexico Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.10.3.2 Key Country Dynamics
      • 7.10.3.3 Regulatory Framework
      • 7.10.3.4 Competitive Scenario
      • 7.10.3.5 Import Export Scenario
      • 7.10.3.6 Investments Scenario
    • 7.10.4 Argentina
      • 7.10.4.1 Argentina Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.10.4.2 Key Country Dynamics
      • 7.10.4.3 Regulatory Framework
      • 7.10.4.4 Competitive Scenario
      • 7.10.4.5 Import Export Scenario
      • 7.10.4.6 Investments Scenario
  • 7.11 MEA
    • 7.11.1 MEA Onychomycosis Market, 2018 - 2030 (USD Million)
    • 7.11.2 South Africa
      • 7.11.2.1 South Africa Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.11.2.2 Key Country Dynamics
      • 7.11.2.3 Regulatory Framework
      • 7.11.2.4 Competitive Scenario
      • 7.11.2.5 Import Export Scenario
      • 7.11.2.6 Investments Scenario
    • 7.11.3 Saudi Arabia
      • 7.11.3.1 Saudi Arabia Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.11.3.2 Key Country Dynamics
      • 7.11.3.3 Regulatory Framework
      • 7.11.3.4 Competitive Scenario
      • 7.11.3.5 Import Export Scenario
      • 7.11.3.6 Investments Scenario
    • 7.11.4 UAE
      • 7.11.4.1 UAE Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.11.4.2 Key Country Dynamics
      • 7.11.4.3 Regulatory Framework
      • 7.11.4.4 Competitive Scenario
      • 7.11.4.5 Import Export Scenario
      • 7.11.4.6 Investments Scenario
    • 7.11.5 Kuwait
      • 7.11.5.1 Kuwait Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.11.5.2 Key Country Dynamics
      • 7.11.5.3 Regulatory Framework
      • 7.11.5.4 Competitive Scenario
      • 7.11.5.5 Import Export Scenario
      • 7.11.5.6 Investments Scenario

Chapter 8 Onychomycosis Market: Company Profiling

  • 8.1 Company Profiles
    • 8.1.1 Bausch Health Companies Inc.,
      • 8.1.1.1 Company Overview
      • 8.1.1.2 Financial Performance
      • 8.1.1.3 Product Benchmarking
      • 8.1.1.4 Strategic Initiatives
    • 8.1.2 Gsk Plc
      • 8.1.2.1 Company Overview
    • 8.1.2 2.Financial Performance
      • 8.1.2.3 Product Benchmarking
      • 8.1.2.4 Strategic Initiatives
    • 8.1.3 Abbott
      • 8.1.3.1 Company Overview
      • 8.1.3.2 Financial Performance
      • 8.1.3.3 Product Benchmarking
      • 8.1.3.4 Strategic Initiatives
    • 8.1.4 F. Pfizer Inc.,
      • 8.1.4.1 Company Overview
      • 8.1.4.2 Financial Performance
      • 8.1.4.3 Product Benchmarking
      • 8.1.4.4 Strategic Initiatives
    • 8.1.5 Bayer Ag
      • 8.1.5.1 Company Overview
      • 8.1.5.2 Financial Performance
      • 8.1.5.3 Product Benchmarking
      • 8.1.5.4 Strategic Initiatives
    • 8.1.6 Teva Pharmaceutical Industries, Ltd.
      • 8.1.6.1 Company Overview
      • 8.1.6.2 Financial Performance
      • 8.1.6.3 Product Benchmarking
      • 8.1.6.4 Strategic Initiatives
    • 8.1.7 Cipla Inc.
      • 8.1.7.1 Company Overview
      • 8.1.7.2 Financial Performance
      • 8.1.7.3 Product Benchmarking
      • 8.1.7.4 Strategic Initiatives
    • 8.1.8 Novartis Ag
      • 8.1.8.1 Company Overview
      • 8.1.8.2 Financial Performance
      • 8.1.8.3 Product Benchmarking
      • 8.1.8.4 Strategic Initiatives
    • 8.1.9 Sun Pharmaceutical Industries Ltd.
      • 8.1.9.1 Company Overview
      • 8.1.9.2 Financial Performance
      • 8.1.9.3 Product Benchmarking
      • 8.1.9.4 Strategic Initiatives
    • 8.1.10 Merck & Co., Inc.
      • 8.1.10.1 Company Overview
      • 8.1.10.2 Financial Performance
      • 8.1.10.3 Product Benchmarking
      • 8.1.10.4 Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Incidence of Diseases
  • Table 4 Global Onychomycosis Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 North America Onychomycosis Market, By Country, 2018 - 2030 (USD Million)
  • Table 6 North America Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 7 North America Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 8 U.S. Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 9 U.S. Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 10 Canada Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 11 Canada Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 12 Europe Onychomycosis Market, By Country, 2018 - 2030 (USD Million)
  • Table 13 Europe Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 14 Europe Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 15 Germany Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 16 Germany Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 17 U.K. Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 18 U.K. Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 19 France Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 20 France Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 21 Italy Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 22 Italy Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 23 Spain Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 24 Spain Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 25 Denmark Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 26 Denmark Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 27 Sweden Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 28 Sweden Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 29 Norway Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 30 Norway Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific Onychomycosis Market, By Country, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific Onychomycosis Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 34 Japan Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 35 Japan Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 36 China Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 37 China Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 38 India Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 39 India Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 40 South Korea Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 41 South Korea Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 42 Australia Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 43 Australia Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 44 Thailand Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 45 Thailand Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 46 Latin America Onychomycosis Market, By Country, 2018 - 2030 (USD Million)
  • Table 47 Latin America Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 48 Latin America Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 49 Brazil Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 50 Brazil Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 51 Mexico Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 52 Mexico Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 53 Argentina Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 54 Argentina Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa Onychomycosis Market, By Country, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 60 South Africa Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 61 South Africa Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 62 UAE Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 63 UAE Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 64 Kuwait Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 65 Kuwait Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Onychomycosis Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 Penetration & Growth Prospect Mapping
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Market Penetration & Growth Prospect Mapping
  • Fig. 15 Onychomycosis market: Type outlook and key takeaways
  • Fig. 16 Onychomycosis market: Type movement analysis & market share 2022 & 2030
  • Fig. 17 Distal subungual onychomycosis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 White superficial onychomycosis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Proximal subungual onychomycosis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Onychomycosis market: Treatment outlook and key takeaways
  • Fig. 22 Onychomycosis market: Treatment movement analysis & market share 2022 & 2030
  • Fig. 23 Oral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Topical market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Regional Marketplace: Key Takeaways
  • Fig. 27 Regional Outlook, 2022 & 2030
  • Fig. 28 Regional Market Dashboard
  • Fig. 29 Regional Market Place: Key Takeaways
  • Fig. 30 North America, SWOT Analysis
  • Fig. 31 Europe, SWOT Analysis
  • Fig. 32 Asia Pacific, SWOT Analysis
  • Fig. 33 Latin America, SWOT Analysis
  • Fig. 34 MEA, SWOT Analysis
  • Fig. 35 North America
  • Fig. 36 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 37 U.S.
  • Fig. 38 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Canada
  • Fig. 40 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Europe
  • Fig. 42 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 43 U.K.
  • Fig. 44 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Germany
  • Fig. 46 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 47 France
  • Fig. 48 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Italy
  • Fig. 50 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Spain
  • Fig. 52 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Denmark
  • Fig. 54 Denmark Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Sweden
  • Fig. 56 Sweden Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Norway
  • Fig. 58 Norway Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Asia Pacific
  • Fig. 60 Asia-Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Japan
  • Fig. 62 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 63 China
  • Fig. 64 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 65 India
  • Fig. 66 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Australia
  • Fig. 68 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Thailand
  • Fig. 70 Thailand Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 71 South Korea
  • Fig. 72 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Latin America
  • Fig. 74 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Brazil
  • Fig. 76 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Mexico
  • Fig. 78 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 79 Argentina
  • Fig. 80 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 81 MEA
  • Fig. 82 MEA Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 83 South Africa
  • Fig. 84 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Saudi Arabia
  • Fig. 86 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 87 UAE
  • Fig. 88 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 89 Kuwait
  • Fig. 90 Kuwait Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Strategy Mapping